UNSPSC 51284032: Guamecycline dihydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C29H38N8O8.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DL609MM5I8, chemically known as 2-naphthacenecarboxamide, n-((4-(((aminoiminomethyl)amino)iminomethyl)-1-piperazinyl)methyl)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride (1:2), (4s,4as,5as,6s,12as)-, but more generally known as guamecycline dihydrochloride, which bears US NIH Compound Identifier 5464418.

UNSPSC 51284032 Guamecycline dihydrochloride is a Commodity code that captures pharmaceutical active ingredients and finished-form medications procured by state and local health agencies. Recent state and local procurement activity shows little direct alignment with the code's nominal scope — the posted opportunities under this code designation actually solicit doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone, indicating a mismatch between the code assignment and the products actually being bought. State and local issuing bodies acquiring under this code include state departments of health and county health authorities. Illinois Department of Public Health and Seminole County, Florida represent the jurisdictions visible in recent awards and open solicitations.

Illinois Department of Public Health awarded a piggyback pharmaceutical contract to Chartwell Rx LLC on August 28, 2026 for doxycycline hyclate 100 mg tablets and ciprofloxacin hydrochloride 500 mg tablets through the MMCAP Infuse cooperative purchasing vehicle, with a total contract value of $2,999,999.11 over three years including renewals; the award followed an Invitation for Bid process. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Recent activity concentrates in Florida and Illinois, with procurement driven by public health preparedness and community health initiatives. No set-aside or preference programs are identified in the posted opportunities.